Document is current
Any future updates will be listed below
-
Authors
Frisk, Christoffer
Das, Sarbashis
Eriksson, Maria J.
Walentinsson, Anna
Corbascio, Matthias
Hage, Camilla
Kumar, Chanchal
Ekström, Mattias
Maret, Eva
Persson, Hans
Linde, Cecilia
Persson, Bengt
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2018-0899, 2020-01978)
Science for Life Laboratory–Astra Zeneca; Mölndal, Sweden collaborative grant (1377)
Uppsala University
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 29 February 2024
First Online: 9 March 2024
Competing interests
: CH reports: consulting fees from Novartis, Roche Diagnostics and AnaCardio, research grants from Bayer and speaker and honoraria from AstraZeneca and Novartis. ME reports: research grants from Novartis Foundation for Medical-Biological Research. HP reports: research grants from AstraZeneca, Novartis, Roche, Stockholm County Council, Vinnova, Swedish Research Council and Swedish Heart–Lung-foundation, speakers’ honoraria from Vifor, AstraZeneca and Novartis. The other authors declare no competing interests.
